Correlation Between Replimune and Vaxcyte
Can any of the company-specific risk be diversified away by investing in both Replimune and Vaxcyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Replimune and Vaxcyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Replimune Group and Vaxcyte, you can compare the effects of market volatilities on Replimune and Vaxcyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Replimune with a short position of Vaxcyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Replimune and Vaxcyte.
Diversification Opportunities for Replimune and Vaxcyte
Average diversification
The 3 months correlation between Replimune and Vaxcyte is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and Vaxcyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxcyte and Replimune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Replimune Group are associated (or correlated) with Vaxcyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxcyte has no effect on the direction of Replimune i.e., Replimune and Vaxcyte go up and down completely randomly.
Pair Corralation between Replimune and Vaxcyte
Given the investment horizon of 90 days Replimune is expected to generate 10.02 times less return on investment than Vaxcyte. In addition to that, Replimune is 1.58 times more volatile than Vaxcyte. It trades about 0.0 of its total potential returns per unit of risk. Vaxcyte is currently generating about 0.06 per unit of volatility. If you would invest 4,405 in Vaxcyte on November 9, 2024 and sell it today you would earn a total of 4,497 from holding Vaxcyte or generate 102.09% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Replimune Group vs. Vaxcyte
Performance |
| Timeline |
| Replimune Group |
| Vaxcyte |
Replimune and Vaxcyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Replimune and Vaxcyte
The main advantage of trading using opposite Replimune and Vaxcyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Replimune position performs unexpectedly, Vaxcyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcyte will offset losses from the drop in Vaxcyte's long position.| Replimune vs. Nuvalent | Replimune vs. Ventyx Biosciences | Replimune vs. Ascendis Pharma AS | Replimune vs. United Therapeutics |
| Vaxcyte vs. Larimar Therapeutics | Vaxcyte vs. Syndax Pharmaceuticals | Vaxcyte vs. Merus BV | Vaxcyte vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |